The lack of effect of sotalol in short QT syndrome patients carrying the T618I mutation in the KCNH2 gene

Carla Giustetto; Chiara Scrocco; Daniela Giachino; Claudio Rapezzi; Barbara Mognetti; Fiorenzo Gaita

doi:10.1016/j.hrcr.2015.07.001

The lack of effect of sotalol in short QT syndrome patients carrying the T618I mutation in the KCNH2 gene

HeartRhythm Case Rep. 2015 Jul 14;1(5):373-378. doi: 10.1016/j.hrcr.2015.07.001. eCollection 2015 Sep.

Authors

Carla Giustetto¹, Chiara Scrocco¹, Daniela Giachino^{2

3}, Claudio Rapezzi⁴, Barbara Mognetti⁵, Fiorenzo Gaita¹

Affiliations

¹ Division of Cardiology, University of Torino, Department of Medical Sciences, Città della Salute e della Scienza Hospital, Torino, Italy.
² Medical Genetics, University of Torino, Department of Clinical and Biological Sciences, Torino, Italy.
³ Medical Genetics San Luigi University Hospital, Orbassano, Italy.
⁴ Institute of Cardiology, University of Bologna, and S. Orsola-Malpighi Hospital, Bologna, Italy.
⁵ Pharmacology Unit, University of Torino, Department of Clinical and Biological Sciences, Torino, Italy.

No abstract available

Keywords: Drug therapy; EPS, electrophysiological study; Genetics; HQ, hydroquinidine; HR, heart rate; Hydroquinidine; Polymorphisms; QTc, corrected QT; Short QT syndrome; Sotalol; Sudden death; nsVT, nonsustained ventricular tachycardia.

Publication types

Case Reports